Gene · 64321
Papers4,189
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,189
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene expression studies of WT1 mutant Wilms tumor cell lines in the frame work of published kidney development data reveals their early kidney stem cell origin. | PLoS One | 2023 | 36689432 | PubTator, text mining | PubMed |
| Engineering placenta-like organoids containing endogenous vascular cells from human-induced pluripotent stem cells. | Bioeng Transl Med | 2023 | 36684087 | PubTator, text mining | PubMed |
| Using CRISPR/Cas9 to generate a heterozygous COL2A1 p.R719C iPSC line (MCRIi019-A-6) model of human precocious osteoarthritis. | Stem Cell Res | 2023 | 36682125 | PubTator, text mining | PubMed |
| Epithelial disruption drives mesendoderm differentiation in human pluripotent stem cells by enabling TGF-β protein sensing. | Nat Commun | 2023 | 36681697 | PubTator, text mining | PubMed |
| Evolutionary Landscape of SOX Genes to Inform Genotype-to-Phenotype Relationships. | Genes (Basel) | 2023 | 36672963 | PubTator, text mining | PubMed |
| The Generation of Human iPSC Lines from Three Individuals with Dravet Syndrome and Characterization of Neural Differentiation Markers in iPSC-Derived Ventral Forebrain Organoid Model. | Cells | 2023 | 36672274 | PubTator, text mining | PubMed |
| De Novo Generation of Human Hematopoietic Stem Cells from Pluripotent Stem Cells for Cellular Therapy. | Cells | 2023 | 36672255 | PubTator, text mining | PubMed |
| Essential Role of Adhesion GPCR, GPR123, for Human Pluripotent Stem Cells and Reprogramming towards Pluripotency. | Cells | 2023 | 36672239 | PubTator, text mining | PubMed |
| Fabrication Scaffold with High Dimensional Control for Spheroids with Undifferentiated iPS Cell Properties. | Cells | 2023 | 36672213 | PubTator, text mining | PubMed |
| Concise Review: Bioengineering of Limbal Stem Cell Niche. | Bioengineering (Basel) | 2023 | 36671683 | PubTator, text mining | PubMed |
| The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies. | Curr Oncol | 2023 | 36661697 | PubTator, text mining | PubMed |
| Lung Cancer Gene Regulatory Network of Transcription Factors Related to the Hallmarks of Cancer. | Curr Issues Mol Biol | 2023 | 36661515 | PubTator, text mining | PubMed |
| Binary Colloidal Crystals Promote Cardiac Differentiation of Human Pluripotent Stem Cells via Nuclear Accumulation of SETDB1. | ACS Nano | 2023 | 36655945 | PubTator, text mining | PubMed |
| Human-induced pluripotent stem cell-derived cerebral organoid of leukoencephalopathy with vanishing white matter. | CNS Neurosci Ther | 2023 | 36650674 | PubTator, text mining | PubMed |
| Single-cell RNA-seq integrated with multi-omics reveals SERPINE2 as a target for metastasis in advanced renal cell carcinoma. | Cell Death Dis | 2023 | 36646679 | PubTator, text mining | PubMed |
| Factors within the Developing Embryo and Ovarian Microenvironment That Influence Primordial Germ Cell Fate. | Sex Dev | 2023 | 36646055 | PubTator, text mining | PubMed |
| Generation of two human iPSC lines with Exon 3 mutations in BCL2-Associated Athanogene 3 (BAG3) from dilated cardiomyopathy patients. | Stem Cell Res | 2023 | 36642055 | PubTator, text mining | PubMed |
| Plasma cell-free DNA methylome profiling in pre- and post-surgery oral cavity squamous cell carcinoma. | Mol Carcinog | 2023 | 36636912 | PubTator, text mining | PubMed |
| STRA6 is essential for induction of vascular smooth muscle lineages in human embryonic cardiac outflow tract development. | Cardiovasc Res | 2023 | 36635482 | PubTator, text mining | PubMed |
| Dynamic network biomarker factors orchestrate cell-fate determination at tipping points during hESC differentiation. | Innovation (Camb) | 2023 | 36632190 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64321/papers?page=34